Zoetis Inc (ZTS) Shares Bought by Mitsubishi UFJ Kokusai Asset Management Co. Ltd.

Mitsubishi UFJ Kokusai Asset Management Co. Ltd. boosted its stake in shares of Zoetis Inc (NYSE:ZTS) by 1.5% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 82,653 shares of the company’s stock after acquiring an additional 1,213 shares during the quarter. Mitsubishi UFJ Kokusai Asset Management Co. Ltd.’s holdings in Zoetis were worth $5,959,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the business. Wilbanks Smith & Thomas Asset Management LLC lifted its holdings in Zoetis by 1.8% in the 2nd quarter. Wilbanks Smith & Thomas Asset Management LLC now owns 5,682 shares of the company’s stock worth $354,000 after buying an additional 98 shares during the period. Scotia Capital Inc. lifted its holdings in Zoetis by 1.5% in the 2nd quarter. Scotia Capital Inc. now owns 9,628 shares of the company’s stock worth $601,000 after buying an additional 142 shares during the period. Dynamic Technology Lab Private Ltd lifted its holdings in Zoetis by 7.3% in the 2nd quarter. Dynamic Technology Lab Private Ltd now owns 5,901 shares of the company’s stock worth $368,000 after buying an additional 401 shares during the period. Sandy Spring Bank lifted its holdings in Zoetis by 2.3% in the 4th quarter. Sandy Spring Bank now owns 31,018 shares of the company’s stock worth $2,235,000 after buying an additional 708 shares during the period. Finally, Wendell David Associates Inc. lifted its holdings in Zoetis by 8.4% in the 4th quarter. Wendell David Associates Inc. now owns 10,300 shares of the company’s stock worth $742,000 after buying an additional 800 shares during the period. Institutional investors and hedge funds own 93.72% of the company’s stock.

A number of research analysts have recently commented on ZTS shares. Zacks Investment Research cut Zoetis from a “hold” rating to a “sell” rating and set a $83.00 target price for the company. in a research note on Saturday, January 13th. Morgan Stanley upgraded Zoetis from an “equal weight” rating to an “overweight” rating and set a $80.00 target price for the company in a research note on Wednesday, November 29th. Jefferies Group restated a “buy” rating on shares of Zoetis in a research note on Friday, November 10th. Craig Hallum restated a “buy” rating and issued a $85.00 target price (up previously from $77.00) on shares of Zoetis in a research note on Tuesday, January 2nd. Finally, BidaskClub upgraded Zoetis from a “hold” rating to a “buy” rating in a research note on Tuesday, November 7th. Two investment analysts have rated the stock with a sell rating, four have assigned a hold rating and fourteen have given a buy rating to the company’s stock. The company currently has an average rating of “Buy” and a consensus target price of $73.72.

Zoetis Inc (NYSE:ZTS) traded up $2.99 during trading on Thursday, hitting $77.45. The company’s stock had a trading volume of 2,851,048 shares, compared to its average volume of 2,897,723. The company has a market cap of $35,688.99, a price-to-earnings ratio of 39.96, a price-to-earnings-growth ratio of 1.62 and a beta of 1.07. Zoetis Inc has a twelve month low of $52.00 and a twelve month high of $81.40. The company has a current ratio of 2.80, a quick ratio of 1.95 and a debt-to-equity ratio of 2.45.

Zoetis (NYSE:ZTS) last posted its earnings results on Thursday, February 15th. The company reported $0.69 EPS for the quarter, topping the Zacks’ consensus estimate of $0.66 by $0.03. The business had revenue of $1.46 billion during the quarter, compared to analyst estimates of $1.40 billion. Zoetis had a return on equity of 62.39% and a net margin of 18.29%. The company’s quarterly revenue was up 14.3% compared to the same quarter last year. During the same quarter last year, the company earned $0.47 EPS. research analysts expect that Zoetis Inc will post 2.36 earnings per share for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, June 1st. Shareholders of record on Friday, April 20th will be issued a $0.126 dividend. This represents a $0.50 dividend on an annualized basis and a dividend yield of 0.65%. The ex-dividend date is Thursday, April 19th. Zoetis’s payout ratio is 26.32%.

COPYRIGHT VIOLATION NOTICE: “Zoetis Inc (ZTS) Shares Bought by Mitsubishi UFJ Kokusai Asset Management Co. Ltd.” was reported by Week Herald and is owned by of Week Herald. If you are reading this piece on another publication, it was illegally copied and republished in violation of US & international trademark and copyright laws. The original version of this piece can be read at https://weekherald.com/2018/02/15/zoetis-inc-zts-shares-bought-by-mitsubishi-ufj-kokusai-asset-management-co-ltd.html.

About Zoetis

Zoetis Inc is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The Company has a business, commercializing products across eight core species: cattle, swine, poultry, sheep and fish (collectively, livestock) and dogs, cats and horses (collectively, companion animals), and within five product categories: anti-infectives, vaccines, parasiticides, medicated feed additives and other pharmaceuticals.

Institutional Ownership by Quarter for Zoetis (NYSE:ZTS)

Receive News & Ratings for Zoetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zoetis and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply